Fierce Pharma
Fierce Biotech
Fierce Healthcare
Fierce Life Sciences Events
Advertise
About Us
Pharma
Vaccines
Asia
Cell & Gene Therapy
Drug Delivery
Executives
Manufacturing
Facilities
Recalls
Warning Letters
Marketing
Special Reports
Fierce 50
Special Report
Awards Gala
Trending
Oncology
Supply Chain
AI and Machine Learning
Awards
Outsourcing Awards
Innovation Awards
Pharma Marketing Awards
Resources
Podcasts
Fierce Events
Industry Events
Webinars
Whitepapers
Survey
Events
Subscribe
Subscribe
Pharma
Vaccines
Asia
Cell & Gene Therapy
Drug Delivery
Executives
Manufacturing
Facilities
Recalls
Warning Letters
Marketing
Special Reports
Fierce 50
Special Report
Awards Gala
Trending
Oncology
Supply Chain
AI and Machine Learning
Awards
Outsourcing Awards
Innovation Awards
Pharma Marketing Awards
Resources
Podcasts
Fierce Events
Industry Events
Webinars
Whitepapers
Survey
Events
Subscribe
Fierce Pharma
Fierce Biotech
Fierce Healthcare
Fierce Life Sciences Events
Advertise
About Us
Truqap
Fierce Biotech
FDA flags concerns for AZ's camizestrant, Truqap ahead of adcomm
The FDA has taken issue with camizestrant's trial design and questions the Truqap data's clinical meaningfulness.
Angus Liu
Apr 28, 2026 2:47pm
Fierce Biotech
FDA to end 9-month adcomm hiatus with review of AZ cancer drugs
Mar 6, 2026 11:16am
Novartis' Pluvicto slows progression in earlier prostate cancer
Oct 19, 2025 10:30am
AstraZeneca unfolds 1st TV ad for breast cancer med Truqap
Apr 30, 2025 12:31pm
AstraZeneca's Truqap falls short in another phase 3 trial
Apr 29, 2025 3:26pm
AZ's Truqap carves path in prostate cancer with phase 3 win
Nov 25, 2024 11:12am
